Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Parenteral
Thickeners and Stabilizers
Coating Systems & Additives
Taste Masking
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Finished Drug Prices
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Annual Reports
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 482
2019 Revenue in Millions : 486
Growth (%) : -1
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 4,996
2019 Revenue in Millions : 5,226
Growth (%) : -4
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 291
2018 Revenue in Millions : 334
Growth (%) : -13
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 1,699
2018 Revenue in Millions : 2,112
Growth (%) : -20
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 1,350
2019 Revenue in Millions : 1,699
Growth (%) : -21
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 498
2020 Revenue in Millions : 482
Growth (%) : 3
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 4,465
2020 Revenue in Millions : 4,996
Growth (%) : -11
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 1,185
2020 Revenue in Millions : 1,350
Growth (%) : -12
Main Therapeutic Indication : Dermatology
Currency : USD
2021 Revenue in Millions : 63
2020 Revenue in Millions : 74
Growth (%) : -15
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 441
2021 Revenue in Millions : 498
Growth (%) : -11
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
